131 related articles for article (PubMed ID: 9565090)
1. Biochemical, pathological, and clinical response to transplantation of normal bone marrow cells into acid sphingomyelinase-deficient mice.
Miranda SR; Erlich S; Friedrich VL; Haskins ME; Gatt S; Schuchman EH
Transplantation; 1998 Apr; 65(7):884-92. PubMed ID: 9565090
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann-Pick disease.
Miranda SR; Erlich S; Friedrich VL; Gatt S; Schuchman EH
Gene Ther; 2000 Oct; 7(20):1768-76. PubMed ID: 11083499
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation in acid sphingomyelinase-deficient mice: engraftment and cell migration into the brain as a function of radiation, age, and phenotype.
Miranda SR; Erlich S; Visser JW; Gatt S; Dagan A; Friedrich VL; Schuchman EH
Blood; 1997 Jul; 90(1):444-52. PubMed ID: 9207482
[TBL] [Abstract][Full Text] [Related]
4. Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span.
Jin HK; Carter JE; Huntley GW; Schuchman EH
J Clin Invest; 2002 May; 109(9):1183-91. PubMed ID: 11994407
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the lung pathology and alveolar macrophage function in the acid sphingomyelinase--deficient mouse model of Niemann-Pick disease.
Dhami R; He X; Gordon RE; Schuchman EH
Lab Invest; 2001 Jul; 81(7):987-99. PubMed ID: 11454988
[TBL] [Abstract][Full Text] [Related]
6. Alterations of myelin-specific proteins and sphingolipids characterize the brains of acid sphingomyelinase-deficient mice, an animal model of Niemann-Pick disease type A.
Buccinnà B; Piccinini M; Prinetti A; Scandroglio F; Prioni S; Valsecchi M; Votta B; Grifoni S; Lupino E; Ramondetti C; Schuchman EH; Giordana MT; Sonnino S; Rinaudo MT
J Neurochem; 2009 Apr; 109(1):105-15. PubMed ID: 19187445
[TBL] [Abstract][Full Text] [Related]
7. Alveolar lipoproteinosis in an acid sphingomyelinase-deficient mouse model of Niemann-Pick disease.
Ikegami M; Dhami R; Schuchman EH
Am J Physiol Lung Cell Mol Physiol; 2003 Mar; 284(3):L518-25. PubMed ID: 12495943
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease.
Dodge JC; Clarke J; Song A; Bu J; Yang W; Taksir TV; Griffiths D; Zhao MA; Schuchman EH; Cheng SH; O'Riordan CR; Shihabuddin LS; Passini MA; Stewart GR
Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17822-7. PubMed ID: 16301517
[TBL] [Abstract][Full Text] [Related]
9. Mannose 6-phosphate receptor-mediated uptake is defective in acid sphingomyelinase-deficient macrophages: implications for Niemann-Pick disease enzyme replacement therapy.
Dhami R; Schuchman EH
J Biol Chem; 2004 Jan; 279(2):1526-32. PubMed ID: 14557264
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo gene therapy using bone marrow-derived cells: combined effects of intracerebral and intravenous transplantation in a mouse model of Niemann-Pick disease.
Jin HK; Schuchman EH
Mol Ther; 2003 Dec; 8(6):876-85. PubMed ID: 14664789
[TBL] [Abstract][Full Text] [Related]
11. Intracerebral transplantation of adult mouse neural progenitor cells into the Niemann-Pick-A mouse leads to a marked decrease in lysosomal storage pathology.
Shihabuddin LS; Numan S; Huff MR; Dodge JC; Clarke J; Macauley SL; Yang W; Taksir TV; Parsons G; Passini MA; Gage FH; Stewart GR
J Neurosci; 2004 Nov; 24(47):10642-51. PubMed ID: 15564580
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation in newborn rats with mucopolysaccharidosis type VI: biochemical, pathological, and clinical findings.
Simonaro CM; Haskins ME; Kunieda T; Evans SM; Visser JW; Schuchman EH
Transplantation; 1997 May; 63(10):1386-93. PubMed ID: 9175798
[TBL] [Abstract][Full Text] [Related]
13. AAV8-mediated hepatic expression of acid sphingomyelinase corrects the metabolic defect in the visceral organs of a mouse model of Niemann-Pick disease.
Barbon CM; Ziegler RJ; Li C; Armentano D; Cherry M; Desnick RJ; Schuchman EH; Cheng SH
Mol Ther; 2005 Sep; 12(3):431-40. PubMed ID: 16099409
[TBL] [Abstract][Full Text] [Related]
14. Infusion of recombinant human acid sphingomyelinase into niemann-pick disease mice leads to visceral, but not neurological, correction of the pathophysiology.
Miranda SR; He X; Simonaro CM; Gatt S; Dagan A; Desnick RJ; Schuchman EH
FASEB J; 2000 Oct; 14(13):1988-95. PubMed ID: 11023983
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel biomarkers for Niemann-Pick disease using gene expression analysis of acid sphingomyelinase knockout mice.
Dhami R; Passini MA; Schuchman EH
Mol Ther; 2006 Mar; 13(3):556-64. PubMed ID: 16214420
[TBL] [Abstract][Full Text] [Related]
16. Injection of mouse and human neural stem cells into neonatal Niemann-Pick A model mice.
Sidman RL; Li J; Stewart GR; Clarke J; Yang W; Snyder EY; Shihabuddin LS
Brain Res; 2007 Apr; 1140():195-204. PubMed ID: 17289003
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary delivery of recombinant acid sphingomyelinase improves clearance of lysosomal sphingomyelin from the lungs of a murine model of Niemann-Pick disease.
Ziegler RJ; Brown C; Barbon CM; D'Angona AM; Schuchman EH; Andrews L; Thurberg BL; McPherson JM; Karey KP; Cheng SH
Mol Genet Metab; 2009 May; 97(1):35-42. PubMed ID: 19231265
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence-based selection of gene-corrected hematopoietic stem and progenitor cells from acid sphingomyelinase-deficient mice: implications for Niemann-Pick disease gene therapy and the development of improved stem cell gene transfer procedures.
Erlich S; Miranda SR; Visser JW; Dagan A; Gatt S; Schuchman EH
Blood; 1999 Jan; 93(1):80-6. PubMed ID: 9864149
[TBL] [Abstract][Full Text] [Related]
19. An animal model of human acid sphingomyelinase deficiency (Niemann-Pick disease) and the study of its enzyme replacement (the Japan Society of Human Genetics award lecture).
Kitagawa T
Jinrui Idengaku Zasshi; 1987 Jun; 32(2):55-69. PubMed ID: 2830422
[No Abstract] [Full Text] [Related]
20. Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency:the utility of animal models of disease in the toxicological evaluation of potential therapeutics.
Murray JM; Thompson AM; Vitsky A; Hawes M; Chuang WL; Pacheco J; Wilson S; McPherson JM; Thurberg BL; Karey KP; Andrews L
Mol Genet Metab; 2015 Feb; 114(2):217-25. PubMed ID: 25092414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
